SABR: Clinical Trials

32 trials of SABR, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

11 recruiting, 6 active not recruiting, 5 completed, 3 not yet recruiting. 32 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable32Recruiting 11, Active not recruiting 6, Completed 5, Not yet recruiting 3, Withdrawn 3, Terminated 2, Unknown 2

Follow SABR: new trials by email Literature Review of SABR trials Research Report on SABR

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Using an Artificial Intelligence Software Tool (iSeg) During Radiation Treatment Planning for Patients With Lung Tumors
Artificial Intelligence-based Intervention, Best Practice, Computed Tomography - Lung Carcinoma, Lung Non-Small Cell Carcinoma
Not applicableNot yet recruitingNorthwestern University342027-02-132026-10-27
Conformal Ablative Radiotherapy in Older Women (CARMEN) With Breast Cancer Undergoing Non-Operative Management
SABR - Breast Cancer Female
Not applicableRecruitingUniversity of Kansas Medical Center182025-11-042026-02-10
SABR PRIMER - Evaluating Stereotactic Ablative Radiotherapy for Primary and Regional Breast Tumors
SABR - Breast Cancer, Metastases
Not applicableNot yet recruitingBritish Columbia Cancer Agency402025-07-012025-04-24
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer
Computed Tomography, Cone-Beam Computed Tomography, Image-Guided Adaptive Radiation Therapy - Localized Prostate Adenocarcinoma, Stage I Prostate Cancer AJCC v8
Not applicableRecruitingMayo Clinic1642024-08-152026-10-14
Low and Intermediate Risk OliGometastatic ColoREctal CancEr PatieNts Treated with Stereotactic ABlative Radiotherapy
SABR - Colorectal Cancer
Not applicableRecruitingIRCCS Sacro Cuore Don Calabria di Negrar2042024-03-182024-12-02
Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy
Minimally invasive pulmonary metastasectomy, Stereotactic ablative radiotherapy - Lung Metastases, Colorectal Cancer Metastatic
Not applicableNot yet recruitingAmsterdam UMC, location VUmc3942024-01-012023-04-11
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography - Lung Carcinoma, Lung Non-Small Cell Carcinoma
Not applicableRecruitingNorthwestern University702023-11-202026-05-29
Primary Breast Oligoprogressive Sites Treated With Radiotherapy to Obviate the Need to Change Systemic Therapy
Biospecimen Collection, Surveys, Stereotactic Body Radiation Therapy (SBRT) - Breast Carcinoma, Anatomic Stage IV Breast Cancer AJCC v8
Not applicableActive not recruitingMayo Clinic452023-10-232026-09-03
VIBE - Virtual Image Guided Brachytherapy Emulation for Locally Advanced Cervical Cancer (LACC)
SBRT - Cervical Cancer
Not applicableUnknownFundacao Champalimaud302023-08-042024-05-01
Daily Adaptive Post-Prostatectomy With Stereotactic Ablative Radiotherapy in Patients With Prostate Cancer
Computed Tomography, Image-Guided Adaptive Radiation Therapy, Magnetic Resonance Imaging - Malignant Prostate Neoplasm
Not applicableActive not recruitingMayo Clinic502023-07-282026-10-26
Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques
Stereotactic ablative radiotherapy - Tachycardia, Ventricular
Not applicableWithdrawnUniversity of Texas Southwestern Medical Center2023-02-012022-08-17
UroLift System With SAbR for Prostate Cancer and BPH
Urolift, SABR - Prostate Cancer
Not applicableCompletedUniversity of Texas Southwestern Medical Center152023-01-112025-10-31
Separation Surgery Followed by Stereotactic Ablative Body Radiotherapy (SABR) Versus SABR Alone for Spinal Metastases
SABR, Separation surgery - Solid Tumor, Spinal Neoplasms
Not applicableRecruitingCancer Research Antwerp1282022-03-072024-09-25
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
High-Dose Rate Brachytherapy, Stereotactic Body Radiation Therapy - Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableRecruitingJonsson Comprehensive Cancer Center522021-08-202026-08-20
5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)
Hypofractionated external beam radiotherapy, High dose rate brachytherapy, Permanent seed implant - Oligometastatic Prostate Cancer
Not applicableRecruitingBritish Columbia Cancer Agency1682021-07-122026-05-06
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial
Cryosurgery, Quality-of-Life Assessment, Stereotactic Body Radiation Therapy - Castration-Resistant Prostate Carcinoma, Metastatic Colorectal Carcinoma
Not applicableRecruitingM.D. Anderson Cancer Center402021-03-162026-04-15
Prostate PMSABR Study
SABR, SOC - Prostate Cancer
Not applicableWithdrawnDarren Poon2021-02-252022-12-09
Germline DNA-Based Radiosensitivity Biomarker Influence on Toxicity Following Prostate Radiotherapy, GARUDA Trial
Discussion, Hypofractionated Radiation Therapy, Laboratory Biomarker Analysis - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableActive not recruitingJonsson Comprehensive Cancer Center2082020-11-102026-07-07
Focal Radiation Therapy for the Treatment of Low or Intermediate-Risk Prostate Cancer
High-Dose Rate Brachytherapy, Quality-of-Life Assessment, Questionnaire Administration - Prostate Adenocarcinoma, Stage I Prostate Cancer American Joint Committee on Cancer (AJCC) v8
Not applicableWithdrawnJonsson Comprehensive Cancer Center2020-04-032020-11-06
Bony M - Stereotactic Ablative Radiotherapy (SABR) of Bony Metastases in Patients With Oligometastatic Disease
SABR - Oligometastatic Disease, Bone Metastases
Not applicableActive not recruitingGitte Fredberg Persson MD PhD672019-11-012023-07-11

Showing 20 of 32. Sign in to see all of them.

Conditions studied

Prostatic Neoplasms (9)  ·  Carcinoma, Non-Small-Cell Lung (5)  ·  Breast Neoplasms (4)  ·  Lung Neoplasms (4)  ·  Neoplasm Metastasis (4)  ·  Colorectal Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Carcinoma, Neuroendocrine (1)  ·  Carcinoma, Renal Cell (1)  ·  Carcinoma, Squamous Cell (1)  ·  Carcinoma, Transitional Cell (1)  ·  Melanoma (1)  ·  Neoplasms (1)  ·  Sarcoma (1)

Sponsors

Jonsson Comprehensive Cancer Center (5)  ·  M.D. Anderson Cancer Center (4)  ·  British Columbia Cancer Agency (3)  ·  Mayo Clinic (3)  ·  Northwestern University (2)  ·  University of Texas Southwestern Medical Center (2)  ·  Amsterdam UMC, location VUmc (1)  ·  Cancer Research Antwerp (1)  ·  Darren Poon (1)  ·  Erasmus Medical Center (1)  ·  Fundacao Champalimaud (1)  ·  Gitte Fredberg Persson MD PhD (1)  ·  IRCCS Sacro Cuore Don Calabria di Negrar (1)  ·  OHSU Knight Cancer Institute (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (20)  ·  Canada (5)  ·  Netherlands (2)  ·  Belgium (1)  ·  Denmark (1)  ·  Italy (1)  ·  Norway (1)  ·  Portugal (1)

Top investigators

Alan C Lee (1)  ·  Amar Kishan (1)  ·  Andrew Loblaw, MD, FRCPC (1)  ·  Aurelie Garant, MD (1)  ·  Bradley J. Stish, M.D. (1)  ·  Carlo Greco, MD (1)  ·  Charlotte Billiet, MD, PhD (1)  ·  Danny Vesprini, MD, FRCPC (1)  ·  Gitte Persson (1)  ·  Henry M Kuerer (1)  ·  Jack Roth, MD, BA (1)  ·  James Daniel, MD (1)  ·  Juanita Crook, MD (1)  ·  Julianne M Pollard (1)  ·  Malcolm Mattes, MD (1)

Results publications

PMID 18618604, PMID 19255320, PMID 19255321, PMID 26104945, PMID 28345951, PMID 30286739, PMID 34529930, PMID 35617923, PMID 36173619, PMID 36306810, PMID 37419394, PMID 37619656, PMID 37707811, PMID 40152443, PMID 40377420, PMID 40714134, PMID 42140754, PMID 42727887, PMID 7799047, PMID 9011700

NIH funding

P30CA060553 (2), P50CA092131 (1)